BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9673375)

  • 41. The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells.
    Yang Y; Lee JH; Kim KY; Song HK; Kim JK; Yoon SR; Cho D; Song KS; Lee YH; Choi I
    Cancer Lett; 2005 Apr; 221(2):191-200. PubMed ID: 15808405
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic value of intratumoral natural killer cells in gastric carcinoma.
    Ishigami S; Natsugoe S; Tokuda K; Nakajo A; Che X; Iwashige H; Aridome K; Hokita S; Aikou T
    Cancer; 2000 Feb; 88(3):577-83. PubMed ID: 10649250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
    Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
    Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N; Tokura Y; Takigawa M; Egawa K
    J Immunol; 1999 Jul; 163(1):242-9. PubMed ID: 10384122
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo.
    Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M
    Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An assessment of peripheral blood lymphocytes populations and subpopulation in patients with stomach cancer].
    Osada J; Kamocki Z; Pietruczuk M; Dabrowska M; Kedra B
    Pol Merkur Lekarski; 2006 Jan; 20(115):26-31. PubMed ID: 16617730
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients.
    Miyahara E; Yamaguchi Y; Minami K; Hihara J; Noma K; Toge T; Takafuta T; Fujimura K
    Anticancer Res; 1999; 19(3A):2057-66. PubMed ID: 10470148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune clearance gastric carcinoma cells in ascites by activating caspase-9-induced apoptosis.
    Chang-Qing F; Yi L; De-Guang W; Qing-Bin S; Xiang-Min H; Na T; Jian-Hua L
    APMIS; 2011 Mar; 119(3):173-9. PubMed ID: 21284734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
    Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
    Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer cell activity of prostatic cancer patients.
    Choe BK; Frost P; Morrison MK; Rose NR
    Cancer Invest; 1987; 5(4):285-91. PubMed ID: 2444316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
    Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
    Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effect of cancerous ascites on natural killer activity].
    Shimura T; Fujimoto S; Ishigami H; Amemiya K; Takahashi O; Okui K
    Gan No Rinsho; 1983 Feb; 29(2):A-9, 133-7. PubMed ID: 6876401
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The progression of invasiveness regarding the role of transforming growth factor beta receptor type II in gastric cancer.
    Tateishi M; Kusaba I; Masuda H; Tanaka T; Matsumata T; Sugimachi K
    Eur J Surg Oncol; 2000 Jun; 26(4):377-80. PubMed ID: 10873359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
    Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
    Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural killer cytolytic activity is associated with the expression of killer cell immunoglobulin-like receptors on peripheral lymphocytes in human.
    Kogure T; Mantani N; Sakai S; Shimada Y; Tamura J; Terasawa K
    Mediators Inflamm; 2003 Apr; 12(2):117-21. PubMed ID: 12775362
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Generation of tumor-reactive effector lymphocytes using tumor RNA-introduced dendritic cells in gastric cancer patients.
    Ohshita A; Yamaguchi Y; Minami K; Okita R; Toge T
    Int J Oncol; 2006 May; 28(5):1163-71. PubMed ID: 16596232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.